Zanubrutinib in Patients With Waldenstr öm's Macroglobulinemia (ARIADNE)

Condition:   Waldenström's Macroglobulinemia Intervention:   Drug: Zanubrutinib Sponsors:   iOMEDICO AG;   BeiGene Switzerland GmbH Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials